AratoMO'ConnorRMeltzerHY; ZEUS Study Group. A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: The Ziprasidone Extended Use in Schizophrenia (ZEUS) study. Int Clin Psychopharmacol2002;17:207–15.
2.
TarsyDBaldessariniRJTaraziFI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs2002;16:23–45.
3.
KeckPEJrVersianiMPotkinSWestSAGillerEIceK.Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry2003;160:741–8.
